What is ANIP's current stock price?

ANIP (ANI Pharmaceuticals, Inc.) is currently trading at $82.72 with a market cap of $1.88B.

What sector is ANI Pharmaceuticals, Inc. in?

ANI Pharmaceuticals, Inc. (ANIP) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

Is ANIP a good stock to buy?

Analysts have a Buy consensus on ANIP with a price target of $124.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

ANIP ANI Pharmaceuticals, Inc.

Healthcare

$82.72-0.06%ClosedMarket Cap: $1.88B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

23.20

PEG

0.05

P/B

3.08

P/S

2.04

EV/EBITDA

8.01

DCF Value

$1,043.40

FCF Yield

8.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

65.9%

Operating Margin

13.4%

Net Margin

9.7%

ROE

17.3%

ROA

6.3%

ROIC

8.2%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$237.5M	$29.5M	$—
Q4 null	$247.1M	$27.5M	$—
FY null	$883.4M	$78.3M	$—
Q3 null	$227.8M	$24.1M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$124.00

Target (Median)

$124.00

Target Range

$124.00 - $124.00

3 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell

GuggenheimBuy

2026-01-16

GuggenheimBuy

2025-11-10

Truist SecuritiesHold

2025-10-09

JP MorganOverweight

2025-09-24

HC Wainwright & Co.Buy

2025-09-17

Trading Activity

Insider Trades

View All

Walsh Patrick Ddirector

SellWed May 13

Walsh Patrick Ddirector

SellWed May 13

Rowland Thomas Andrewofficer: SVP, HEAD - ESTABLISHED BRANDS

SellWed May 13

Lalwani Nikhildirector, officer: PRESIDENT & CEO

SellWed May 13

Gutwerg Oriofficer: SVP, GENERICS

SellWed May 13

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Exchange

—

Beta

0.46

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Peers

BGM